BLOOMINGTON, Ind.--(BUSINESS WIRE)--Just weeks after 2015 country approval of Cook Medical’s Zenith Alpha™ Abdominal Endovascular Graft, the University of Western London Health Sciences Centre in London, Ontario treated the first patient with the device as part of Cook’s Canada commercial launch.
“We would like to the thank Cook for the opportunity to place the first Cook Alpha AAA endograft in North America,” said Adam Power, MD, assistant professor and program director of vascular surgery at University of Western London Health Sciences Centre following 2015 approval. “We are proud of our aortic experience here at Western University and this case enables us to continue pushing innovative approaches to aortic pathology for the best treatment of our patients.”
“We would like to the thank Cook for the opportunity to place the first Cook Alpha AAA endograft in North America,” said Adam Power, MD, assistant professor and program director of vascular surgery at University of Western London Health Sciences Centre following 2015 approval. “We are proud of our aortic experience here at Western University and this case enables us to continue pushing innovative approaches to aortic pathology for the best treatment of our patients.”
